Over the past years Vivostat A/S has successfully implemented a continuous investment of resources in expanding the company’s sales and product activities.
To further accelerate the development of Vivostat the Board has decided to appoint Michael Ruge as new CEO for Vivostat where he will replace Tom Bjerg Lauritzen. Michael Ruge has a strong track record in management as well as international sales and marketing from both large and small corporations.
Michael Ruge will together with the rest of the management team lead Vivostat in the effort to allow more patients to benefit from Vivostat products in surgical settings and in the treatment of chronic wounds. Michael Ruge took up his new position April 1st 2009. For our distribution partners and customers in Vivostat this means business as usual.
Please join us in welcoming Michael Ruge in his new position.
